|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM202228231 |
003 |
DE-627 |
005 |
20250212022952.0 |
007 |
tu |
008 |
231223s2007 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed25n0674.xml
|
035 |
|
|
|a (DE-627)NLM202228231
|
035 |
|
|
|a (NLM)20930942
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Hwang, Taewon
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Anticancer Drug-Phospholipid Conjugate for Enhancement of Intracellular Drug Delivery
|
264 |
|
1 |
|c 2007
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Revised 02.05.2024
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status PubMed-not-MEDLINE
|
520 |
|
|
|a Tumor specific delivery of anti-cancer drugs is one of the major challenges faced by drug development processes. In this study, we prepared a doxorubicin (DOX)-conjugated liposome (DCL) by incorporating the newly synthesized DSPE-PEG2000-DOX (DPD) into liposomes as a lipid component and tested its anti-tumor activity in vivo. DPD was synthesized by coupling DOX to DSPE-PEG2000-COOH via amide linkage and the chemical structure of resulting DPD was confirmed by (1)H-NMR analysis. DCL having liposome size of 130 nm was prepared through thin film cast-hydration method. DCL was found to have significantly higher cellular uptake than conventional liposomes as confirmed by flow cytometry analysis. Anti-tumor activity of DCL against murine B16F10 melanoma tumor-bearing mice revealed that DCL inhibits tumor growth more efficiently than the conventional liposomes, presumably attributed to DOX mediated endocytosis process
|
650 |
|
4 |
|a Journal Article
|
700 |
1 |
|
|a Han, Hee Dong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Song, Chung Kil
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Seong, Hasoo
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kim, Jung Hyun
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chen, Xiaoyuan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Shin, Byung Cheol
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Macromolecular symposia
|d 1999
|g 249-250(2007), 1 vom: 01. Apr., Seite 109-115
|w (DE-627)NLM098235508
|x 1022-1360
|7 nnns
|
773 |
1 |
8 |
|g volume:249-250
|g year:2007
|g number:1
|g day:01
|g month:04
|g pages:109-115
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 249-250
|j 2007
|e 1
|b 01
|c 04
|h 109-115
|